Yahoo Search Busca da Web

Resultado da Busca

  1. 18 de set. de 2020 · Cervical cancer is the fourth most common cancer in women of all ages worldwide. The disease is staged using the International Federation of Gynecology and Obstetrics (FIGO) system, which was updated in 2018. The authors explain the key changes from the 2009 version and the rationale behind them.

  2. 8 de mai. de 2024 · T0: no evidence of primary tumor; Tis: carcinoma in situ (cis) T1: cervical carcinoma confined to the uterus (extension to the corpus should be disregarded) T1a: invasive carcinoma diagnosed only by microscopy (depth of invasion < 5 mm) 11; T1b: clinically visible lesion confined to the cervix

  3. 25 de fev. de 2017 · Invasive carcinoma with measured deepest invasion ≥ 5 mm (greater than stage IA), lesion limited to the cervix . T1b1. IB1. Invasive carcinoma with ≥ 5 mm depth of stromal invasion and < 2 cm...

  4. Cervical cancer is the second most commonly diagnosed cancer and the third leading cause of cancer death among females in less developed countries. There were an estimated 527 600 new cervical cancer cases and 265 700 deaths worldwide in 2012 [1]. Nearly 90% of cervical cancer deaths occurred in developing parts of the world. The large geographic variation in cervical cancer rates reflects ...

  5. T0: No evidence of primary tumor. Tisb: Carcinoma in situ (preinvasive carcinoma). T1: I: Cervical carcinoma confined to uterus (extension to corpus should be disregarded). T1ac: IA: Invasive carcinoma diagnosed only by microscopy.

  6. 22 de jan. de 2019 · T0: No evidence of primary tumour: Tis: Carcinoma in situ (pre-invasive carcinoma), intrepidity neoplasia grade III (VIN III) T1: Tumour confined to vulva or vulva and perineum: T1a: Tumour 2 cm or less in greatest dimension and with stromal invasion no greater than 1.0 mm a: T1b: Tumour greater than 2 cm and or with stromal invasion ...

  7. 14 de dez. de 2022 · The burden of cervical cancer remains high in many parts of the world, and in most countries, the incidence and mortality of the disease remain much higher than the threshold set by the WHO initiative on cervical cancer elimination.